Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis

American Journal of Pathology

Volumn 151, Issue 2, 1997, Pages 539-547

  Nomura, Atsushi ^a   Morita, Yoshiki ^a   Maruyama, Shouichi ^a   Hotta, Nigishi ^a   Nadai, Masayuki ^a   Wang, Li ^a   Hasegawa, Takaaki ^a   Matsuo, Seiichi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; COBROTOXIN; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; COMPLEMENT RECEPTOR; INULIN; PUROMYCIN AMINONUCLEOSIDE; RECOMBINANT COMPLEMENT RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; FEMALE; INTERSTITIAL NEPHRITIS; INULIN CLEARANCE; KIDNEY CLEARANCE; NEPHROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; COBRA VENOMS; COMPLEMENT C3; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT MEMBRANE ATTACK COMPLEX; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; KIDNEY TUBULES; NEPHROSIS; PUROMYCIN AMINONUCLEOSIDE; RATS; RATS, WISTAR;

EID: 0030857577     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Williams PS, Fass G, Bone JM: Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure. Q J Med 1988, 67:343-345
2. Eddy AA, Michael AF: Acute tubulointerstitial nephritis associated with aminonucleoside nephrosis. Kidney Int 1988, 33:14-23
3. Eddy AA: Interstitial nephritis induced by protein-overload protein-uria. Am J Pathol 1989, 135:719-733
4. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal disease. Am J Kidney Dis 1992, 20:1-17
5. Schainuck LI, Striker GE, Cutler RE, Benditt EP: Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1970, 1:631-640
6. Kees-Folts DJ, Sadow L, Schreiner GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994, 45: 1697-1709
7. Ong ACM, Jowett TP, Moorhead JF, Owen JS: Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells. Kidney Int 1994, 46:1315-1321
8. Sanders PW, Herrera GA, Chen A, Booker BB: Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo. J Clin Invest 1988, 82:2086-2096
9. Alfrey AC, Foment DH, Hammond WS: Role of iron in tubulointerstitial injury in nephrotoxic serum nephritis. Kidney Int 1989, 36:753-759
10. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ: Tubulointerstitial disease in glomerulonephritis; potential role of osteopontin (uropontin). Am J Pathol 1994, 144:915-926
11. Eddy AA, Warren JS: Expression and function of monocyte chemoattractant protein-1 in experimental nephrotic syndrome. Clin Immunol Immunopathol 1996, 78:140-151
12. Hirschberg R: Bioreactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role of for insulin-like growth factor. J Clin Invest 1996, 98:116-124
13. Harris KPG, Lefkowith JB, Klahr S, Schreiner GF: Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin. J Clin Invest 1990, 86:1115-1123
14. Camussi G, Rotunno M, Segoloni G, Brentjens JR, Andres GA: In vitro alternative pathway activation of complement by the brush border of proximal tubules of normal rat kidney. J Immunol 1982, 128:1659-1663
15. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S: Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 1994, 46:89-96
16. Weisman HF, Bartow T, Leppo MK, Marsh JHC, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT: Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990, 249:146-151
17. Yeh CG, Marsh HCJ, Carson GR, Berman L, Concino MF, Scesney SM, Kuestner RE, Skibbens R, Donahue KA, Ip SH: Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. J Immunol 1991, 146:250-256
18. Matsuo S, Ichida S, Takizawa H, Okada N, Baranyi L, Iguchi A, Morgan BP, Okada H: In vivo effects of monoclonal antibodies which functionally inhibit complement regulatory proteins in rats. J Exp Med 1994, 180:1619-1627
19. Schulze M, Baker PJ, Perkinson DT, Johnson RJ, Ochi RF, Stahl RAK, Couser WG: Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis. Kidney Int 1989, 35:60-68
20. Watanabe N, Kamei S, Ohkubo A, Yamanaka M, Ohsawa S, Makino K, Tokuda K: Urinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyzer. Clin Chem 1986, 32:1551-1554
21. Ozaki I, Ito Y, Fukatsu A, Suzuki N, Yoshida F, Watanabe Y, Sakamoto N, Matsuo S: A plasma membrane antigen of rat glomerular epithelial cells: antigenic determinants involving N-linked sugar residues in a 140 kilodalton sialoglycoprotein of the podocytes. Lab Invest 1990, 63:707-716
22. Nomura A, Nishikawa K, Yuzawa Y, Okada H, Okada N, Morgan BP, Piddlesden SJ, Nadai M, Hasegawa T, Matsuo S: Tubulointerstitial injury induced in rats by a monoclonal antibody which inhibits function of a membrane inhibitor of complement. J Clin Invest 1995, 96:2348-2356
23. Platt J, Michael AF: Retardation of fading and enhancement of intensity of immunofluorescence by p-phenylene-diamine. J Histochem Cytochem 1983, 31:840-842
24. Prescott LF, Freestone S, McAuslane JAN: The concentration-depenent disposition of intravenous p-aminohippurate in subjects with normal and impaired renal function. Br J Clin Pharmacol 1993, 35:20-29
25. Kinoshita T: Biology of complement: the overture. Immunol Today 1991, 12:2911-295
26. Hostetter MK, Gordon DL: Biochemistry of C3 and related thioester proteins in infection and inflammation. Rev Infect Dis 1987, 9:97-109
27. Hourcade D, Holers VM, Atkinson JP: The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989, 45:381-416
28. Morgan BP, Gasque P: Expression of complement in the brain: role in health and disease. Immunol Today 1996, 17:461-466
29. Witte DP, Welch TR, Beischel LS: Detection and cellular localization of human C4 gene expression in the renal tubular epithelial cells and other extrahepatic epithelial sources. Am J Pathol 1991, 139:717-724
30. Welch TR, Beischel LS, Witte DP: Differential expression of complement C3 and C4 in the human kidney. J Clin Invest 1993, 92:1451-1458
31. Biancone L, David S, Pietra DV, Montrucchio G, Cambi V, Camussi G: Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 1994, 45:451-460
32. Fearon DT: Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci USA 1979, 76:5867-5871
33. Iida K, Nussenzweig V: Complement receptor is an inhibitor of the complement cascade. J Exp Med 1981, 153:1138-1150
34. Pemberton M, Anderson G, Vetvicka V, Justus DE, Ross GD: Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol 1993, 150:5104-5113
35. Couser WG, Johnson RJ, Young BA, Yeh CG, Toth CA, Rudolph AR: The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J Am Soc Nephrol 1995, 5:1888-1894